HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Dennis G Maki Selected Research

Catheters

7/2014Chlorhexidine-impregnated dressing for prevention of catheter-related bloodstream infection: a meta-analysis*.
6/2014Arterial catheters as a source of bloodstream infection: a systematic review and meta-analysis*.
10/2013ACP Journal Club. Review: Antibiotic prophylaxis on removal of urinary catheters reduces symptomatic urinary tract infections.
9/2013The risk of bloodstream infection associated with peripherally inserted central catheters compared with central venous catheters in adults: a systematic review and meta-analysis.
1/2013ACP Journal Club. Clinically indicated and routine replacement of peripheral IV catheters did not differ for phlebitis.
6/2012International Nosocomial Infection Control Consortium (INICC) report, data summary of 36 countries, for 2004-2009.
4/2011A novel antimicrobial and antithrombotic lock solution for hemodialysis catheters: a multi-center, controlled, randomized trial.
6/2010In vitro studies of a novel antimicrobial luer-activated needleless connector for prevention of catheter-related bloodstream infection.
3/2010International Nosocomial Infection Control Consortium (INICC) report, data summary for 2003-2008, issued June 2009.
12/2008Preventing central venous catheter-associated bloodstream infections: development of an antiseptic barrier cap for needleless connectors.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $490.00 USD

Dennis G Maki Research Topics

Disease

42Infection
07/2014 - 03/2002
7Urinary Tract Infections (Urinary Tract Infection)
10/2013 - 01/2002
6Ventilator-Associated Pneumonia (Pneumonia, Ventilator Associated)
06/2012 - 06/2005
5Sepsis (Septicemia)
06/2014 - 12/2002
4Critical Illness (Critically Ill)
06/2014 - 08/2005
4Cross Infection (Nosocomial Infection)
03/2010 - 06/2002
4Communicable Diseases (Infectious Diseases)
04/2008 - 08/2002
4Catheter-Related Infections
10/2005 - 08/2002
3Fever (Fevers)
04/2008 - 12/2002
3Inflammation
05/2005 - 12/2002
2Thrombosis (Thrombus)
04/2011 - 04/2004
2Pneumonia (Pneumonitis)
06/2005 - 05/2005
1Cellulitis
07/2014
1Phlebitis
01/2013
1Thrombocytopenia (Thrombopenia)
04/2011
1Hemorrhage
04/2011
1Chronic Kidney Failure (Chronic Renal Failure)
04/2011
1Septic Shock (Toxic Shock Syndrome)
09/2008
1Flushing
08/2006
1Neoplasms (Cancer)
08/2006
1Wounds and Injuries (Trauma)
01/2006
1Fistula
08/2005
1Renal Insufficiency (Renal Failure)
08/2005
1Hypoglycemia (Reactive Hypoglycemia)
08/2005
1Agranulocytosis (Granulocytopenia)
06/2005
1Ulcer
06/2005
1Confusion (Bewilderment)
05/2005
1Abdominal Pain (Pain, Abdominal)
08/2004
1Bacteremia
05/2004
1Pathologic Constriction (Stenosis)
04/2004
1Pain (Aches)
12/2002
1Erythema
12/2002
1Hemolytic-Uremic Syndrome
08/2002
1Thrombotic Thrombocytopenic Purpura
03/2002
1Ehrlichiosis
03/2002

Drug/Important Bio-Agent (IBA)

9ChlorhexidineIBA
07/2014 - 08/2002
4Methicillin (Metin)FDA Link
06/2012 - 10/2006
4Anti-Bacterial Agents (Antibiotics)IBA
10/2007 - 06/2002
4VancomycinFDA LinkGeneric
08/2006 - 06/2002
3Ceftriaxone (Ceftriaxon)FDA LinkGeneric
03/2010 - 10/2006
3CoagulaseIBA
08/2005 - 12/2002
2ImipenemFDA Link
06/2012 - 03/2010
2Ceftazidime (Fortum)FDA LinkGeneric
06/2012 - 03/2010
2Heparin (Liquaemin)FDA LinkGeneric
04/2011 - 08/2005
2PlasticsIBA
01/2011 - 05/2004
2FluoroquinolonesIBA
11/2008 - 10/2006
2DNA (Deoxyribonucleic Acid)IBA
08/2005 - 12/2002
2Biological Markers (Surrogate Marker)IBA
05/2005 - 07/2003
2drotrecogin alfa activated (Xigris)FDA Link
05/2005 - 07/2003
2Cephalosporins (Cephalosporin Antibiotics)IBA
07/2004 - 06/2002
2antiarrhythmic peptide (AAP)IBA
11/2002 - 08/2002
1Rifampin (Rifampicin)FDA LinkGeneric
07/2013
1DaptomycinFDA Link
07/2013
1methylparabenFDA LinkGeneric
04/2011
1sodium citrateFDA LinkGeneric
04/2011
1Phenobarbital (Luminal)FDA Link
04/2011
1Methylene Blue (Methylthioninium Chloride)FDA Link
04/2011
1propylparabenFDA LinkGeneric
04/2011
1SilverIBA
06/2010
1PiperacillinFDA LinkGeneric
03/2010
1Norepinephrine (Noradrenaline)FDA LinkGeneric
09/2008
1Vasopressins (Vasopressin)IBA
09/2008
1Silver Sulfadiazine (SSD)FDA LinkGeneric
10/2005
1Local Anti-Infective Agents (Antiseptics)IBA
10/2005
1LipidsIBA
08/2005
1Glucose (Dextrose)FDA LinkGeneric
08/2005
1Sucralfate (Carafate)FDA LinkGeneric
06/2005
1Urea (Carbamide)FDA LinkGeneric
05/2005
1Protein CIBA
05/2005
1EnzymesIBA
08/2004
1Ursodeoxycholic Acid (Urso)FDA LinkGeneric
04/2004
1beta-Lactamases (beta-Lactamase)IBA
06/2002
1Doxycycline (Vibramycin)FDA LinkGeneric
03/2002

Therapy/Procedure

33Catheters
07/2014 - 01/2002
5Mechanical Ventilators (Ventilator)
06/2012 - 06/2005
3Critical Care
04/2008 - 08/2002
3Transplants (Transplant)
08/2005 - 04/2004
2Antibiotic Prophylaxis
07/2014 - 10/2013
2Parenteral Nutrition
08/2006 - 08/2005
1Stethoscopes
03/2014
1Renal Dialysis (Hemodialysis)
04/2011
1Oral Hygiene (Dental Hygiene)
06/2005
1Intensive Care (Surgical Intensive Care)
05/2004
1Choledochostomy
04/2004
1Transplantation (Transplant Recipients)
03/2002